Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy.

Chen, Yiqun; Gong, Lingyan; Gu, Pengyang; Hua, Yiwen; Sun, Yingfang; Ni, Songshi; Zhou, Xiaoyu; Tang, Zhiyuan

Chen, Yiqun; Gong, Lingyan; Gu, Pengyang; Hua, Yiwen; Sun, Yingfang; Ni, Songshi; Zhou, Xiaoyu; Tang, Zhiyuan.

Afiliação

Chen Y; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, China.
Gong L; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, China.
Gu P; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, China.
Hua Y; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, China.
Sun Y; Department of Pharmacy, Affiliated Hospital of Nantong University, Pharmacy School of Nantong University, Nantong, 226001, China.
Ni S; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, China. jsntnss@163.com.
Zhou X; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, 226001, China. hx730303@163.com.
Tang Z; Department of Pharmacy, Affiliated Hospital of Nantong University, Pharmacy School of Nantong University, Nantong, 226001, China. tina2951@sina.com.

BMC Cancer ; 23(1): 944, 2023 Oct 06.

Article em En | MEDLINE | ID: mdl-37803437

Assuntos

Carcinoma Pulmonar de Células não Pequenas; Neoplasias Pulmonares; Humanos; Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico; Carcinoma Pulmonar de Células não Pequenas/epidemiologia; Neoplasias Pulmonares/tratamento farmacológico; Neoplasias Pulmonares/epidemiologia; Nivolumabe/uso terapêutico; Estudos Retrospectivos; Imunoterapia/efeitos adversos; Imunoterapia/métodos

Palavras-chave

Blood biomarkers; Dynamics; Immune-checkpoint inhibitors; Immune-related adverse events; Non-small-cell lung cancer; Pan-immune-inflammation value

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google